Skip to main content
logo
MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.1992
+0.0012 (0.61%)
Jul 31, 2026, 5:30 PM CET

SWX:MMTX Revenue

MindMaze Therapeutics Holding had revenue of 609.00K CHF in the quarter ending June 30, 2025, a decrease of -78.18%. This brings the company's revenue in the last twelve months to 4.05M, down -52.81% year-over-year. In the year 2024, MindMaze Therapeutics Holding had annual revenue of 8.42M with 39.52% growth.

Revenue (ttm)
4.05M
Revenue Growth
-52.81%
P/S Ratio
47.35
Revenue / Employee
n/a
Employees
10
Market Cap
30.40M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.42M2.38M39.52%
Dec 31, 20236.03M-48.00K-0.79%
Dec 31, 20226.08M2.76M83.11%
Dec 31, 20213.32M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018565.00K--
Dec 31, 2017---
Dec 31, 201615.00K-242.23K-94.17%
Dec 31, 2015257.23K--
Dec 31, 2014---
Dec 31, 201320.74M-14.19M-40.62%
Dec 31, 201234.93M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bachem Holding AG708.53M
Basilea Pharmaceutica AG232.38M
Idorsia199.71M
Santhera Pharmaceuticals Holding AG77.19M
Newron Pharmaceuticals17.81M
BioVersys AG3.18M
Molecular Partners AG681.00K
Xlife Sciences AG275.31K
Revenue Rankings

MindMaze Therapeutics Holding News

More News